⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
RVPH News
Reviva Pharmaceuticals Holdings, Inc. Common Stock
Reviva Announces Letter to Shareholders
globenewswire.com
RVPH
Form 8-K
sec.gov
RVPH
Reviva Reports Full Year 2025 Financial Results and Recent Business Highlights
globenewswire.com
RVPH
Reviva Pharmaceuticals Holdings, Inc. Announces Closing of $10 Million Public Offering
globenewswire.com
RVPH
Form 8-K
sec.gov
RVPH
Reviva Pharmaceuticals Holdings, Inc. Announces Pricing of $10 Million Public Offering
globenewswire.com
RVPH
Reviva Pharmaceuticals Holdings, Inc. Announces Proposed Public Offering
globenewswire.com
RVPH
Form 8-K
sec.gov
RVPH
Reviva Announces Publication on Clinical Vocal Biomarker Data from the RECOVER Phase 3 Clinical Trial of Brilaroxazine to Treat Negative Symptoms in Schizophrenia
globenewswire.com
RVPH
Reviva to Present at the Sachs 9th Annual Neuroscience Innovation Forum
globenewswire.com
RVPH